Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guideline Platform
  3. Endocrine
  4. Back
  5. Co-morbidities
  6. Coronary Heart Disease and Stroke, Primary and Secondary Prevention (Cholesterol) (181)
Announcements and latest updates

Polyfill.io vulnerability

28 june 2024

Our eHealth team advised us yesterday of an international vulnerability relating to polyfill.io . This domain has become compromised and is  spreading malware through a widespread supply chain attack, estimated to affect over 110,000 websites including major websites such as the BBC. The Polyfill site offered widely used bits of code for older browsers that allowed the use of modern Javascript features. Such code makes the work for web developers easier and allows compatibility with a broader range of browsers. 

Websites that have used the Javascript code from Polyfill have been urged to remove such code immediately. The change occurred after a suspected Chinese firm purchased the domain in early 2024.

Tactuum have identified and are now testing a fix to remove all Polyfill code from the RDS site.. They will be deploying the fix on Monday 1 July along with other planned fixes and amendments. I will notify you of the timing  of the deployment as soon as possible.

In the meantime, please ensure that you have up-to-date anti-virus software installed on your machines and personal devices.

 

Coronary Heart Disease and Stroke, Primary and Secondary Prevention (Cholesterol) (181)

A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments.  

Clinical judgement should be exercised on the applicability of any guideline, influenced by individual patient characteristics. Clinicians should be mindful of the potential for harmful polypharmacy and increased susceptibility to adverse drug reactions in patients with multiple morbidities or frailty.

If, after discussion with the patient or carer, there are good reasons for not following a guideline, it is good practice to record these and communicate them to others involved in the care of the patient.

Resources

Use the button below to access this item.

Access this resource

Editorial Information

Last reviewed: 21/06/2022

Next review date: 30/05/2025

Author(s): John Byrne.

Version: 6

Author email(s): john.byrne@ggc.scot.nhs.uk.

Approved By: Medicines Utilisation Subcommittee of ADTC

Reviewer name(s): John Byrne.

Document Id: 181